|
1.
|
|
17 p, 277.3 KB |
The Influence of Hormonal Factors on the Risk of Developing Cervical Cancer and Pre-Cancer : results from the EPIC Cohort
/
Roura, Esther (Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública) ;
Travier, Noémie (Institut Català d'Oncologia) ;
Waterboer, Tim (German Cancer Research Center (DKFZ), Heidelberg, Germany) ;
De Sanjose, Silvia (Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública) ;
Bosch José, Francesc Xavier 1947- (Institut Català d'Oncologia) ;
Pawlita, Michael (German Cancer Research Center (DKFZ), Heidelberg, Germany) ;
Pala, Valeria (Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy) ;
Weiderpass, Elisabete (Folkhälsan Research Center, Helsinki, Finland) ;
Margall, Núria (Institut d'Investigació Biomèdica Sant Pau) ;
Dillner, Joakim (Karolinska Institutet (Estocolm, Suècia)) ;
Gram, Inger T. (UiT The Arctic University of Norway, Tromsø, Norway) ;
Tjønneland, Anne (Danish Cancer Society Research Center, Copenhagen, Denmark) ;
Munk, Christian (Danish Cancer Society Research Center, Copenhagen, Denmark) ;
Palli, Domenico (Cancer Research and Prevention Institute-ISPO, Florence, Italy) ;
Khaw, Kay-Tee (University of Cambridge) ;
Overvad, Kim (Aarhus University, Aarhus, Denmark) ;
Clavel-Chapelon, Françoise (Institut Gustave Roussy (Villejuif, França)) ;
Mesrine, Sylvie (Institut Gustave Roussy (Villejuif, França)) ;
Fournier, Agnès (Institut Gustave Roussy (Villejuif, França)) ;
Fortner, Renée T. (German Cancer Research Center (DKFZ), Heidelberg, Germany) ;
Ose, Jennifer (German Cancer Research Center (DKFZ), Heidelberg, Germany) ;
Steffen, Annika (German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany) ;
Trichopoulou, Antonia (Hellenic Health Foundation, Athens, Greece) ;
Lagiou, Pagona (Harvard School of Public Health, Boston, United States of America) ;
Orfanos, Philippos (University of Athens Medical School, Athens, Greece) ;
Masala, Giovanna (Cancer Research and Prevention Institute-ISPO, Florence, Italy) ;
Tumino, Rosario ("Civic-M.P. Arezzo" Hospital, Ragusa, Italy) ;
Sacerdote, Carlotta (Centre for Cancer Epidemiology and Prevention (CPO Piemonte), Turin, Italy) ;
Polidoro, Silvia (Human Genetics Foundation (HuGeF), Turin, Italy) ;
Mattiello, Amalia (Federico II University, Naples, Italy) ;
Lund, Eiliv (UiT The Arctic University of Norway, Tromsø, Norway) ;
Peeters, Petra H. (University Medical Center Utrecht, Utrecht, The Netherlands) ;
Bueno-de-Mesquita, H. Bas (University of Malaya, Kuala Lumpur, Malaysia) ;
Quirós, J. Ramón (Dirección de Salud Pública de Asturias) ;
Sánchez, María-José (Instituto de Investigación Sanitaria de Granada) ;
Navarro Sánchez, Carmen (Universidad de Murcia) ;
Barricarte, Aurelio (Instituto de Investigación Sanitaria de Navarra) ;
Larrañaga, Nerea (Biodonostia Osasun Ikerketako Institutura (País Basc)) ;
Ekström, Johanna (Lund University, Medicon Village, Lund, Sweden) ;
Lindquist, David (Department of Radiation Sciences, Umeå University, Umeå, Sweden) ;
Idahl, Annika (Umeå University, Umeå, Sweden) ;
Travis, Ruth C. (University of Oxford, Oxford, United Kingdom) ;
Merritt, Melissa A. (Imperial College London, London, United Kingdom) ;
Gunter, Marc J. (Imperial College London, London, United Kingdom) ;
Rinaldi, Sabina (International Agency for Research on Cancer, Lyon, France) ;
Tommasino, Massimo (International Agency for Research on Cancer, Lyon, France) ;
Franceschi, Silvia (International Agency for Research on Cancer, Lyon, France) ;
Riboli, Elio (Imperial College London, London, United Kingdom) ;
Castellsagué, Xavier (Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública) ;
Universitat Autònoma de Barcelona
In addition to HPV, high parity and hormonal contraceptives have been associated with cervical cancer (CC). However, most of the evidence comes from retrospective case-control studies. The aim of this study is to prospectively evaluate associations between hormonal factors and risk of developing cervical intraepithelial neoplasia grade 3 (CIN3)/carcinoma in situ (CIS) and invasive cervical cancer (ICC). [...]
2016 -  10.1371/journal.pone.0147029
PloS one, Vol. 11 (january 2016)
|
|
|
2.
|
|
14 p, 278.2 KB |
Multidisciplinary, evidence-based consensus guidelines for human papillomavirus (HPV) vaccination in highrisk populations, Spain, 2016
/
Martínez Gómez, Xavier (Hospital Universitari Vall d'Hebron) ;
Curran, Adrian (Hospital Universitari Vall d'Hebron) ;
Campins Martí, Magda (Hospital Universitari Vall d'Hebron) ;
Alemany, Laia (Institut Català d'Oncologia) ;
Rodrigo-Pendás, José Ángel (Hospital Universitari Vall d'Hebron) ;
Borruel, Natalia (Hospital Universitari Vall d'Hebron) ;
Castellsagué, Xavier (Institut Català d'Oncologia) ;
Díaz de Heredia, Cristina (Hospital Universitari Vall d'Hebron) ;
Moraga-Llop, F. A. (Asociación Española de Vacunología) ;
del Pino, M. (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Torné, A. (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Universitat Autònoma de Barcelona
Introduction: Although human papillomavirus (HPV) routine vaccination programmes have been implemented around the world and recommendations have been expanded to include other high-risk individuals, current recommendations often differ between countries in Europe, as well as worldwide. [...]
2019 - 10.2807/1560-7917.ES.2019.24.7.1700857
Eurosurveillance, Vol. 24 Núm. 7 (14 2019) , p. 1700857
|
|
|
3.
|
|
13 p, 297.5 KB |
Predictors of human papillomavirus infection in women undergoing routine cervical cancer screening in Spain : the CLEOPATRE study
/
Roura, Esther (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Iftner, Thomas (University Hospital of Tübingen (Alemanya)) ;
Vidart, José Antonio (Hospital Clínico San Carlos (Madrid)) ;
Kjaer, Susanne Krüger (Copenhagen University Hospital Rigshospitalet) ;
Bosch José, Francesc Xavier 1947- (Institut Germans Trias i Pujol) ;
Muñoz, Nubia (National Cancer Institute (Bogotà, Colòmbia)) ;
Palacios, Santiago (Instituto Palacios. Salud y Medicina de la Mujer (Madrid, Espanya)) ;
Rodriguez, Maria San Martin (Medical Department, Sanofi Pasteur MSD, Madrid, Spain) ;
Morillo, Carmen (Medical Department, Sanofi Pasteur MSD, Madrid, Spain) ;
Serradell, Laurence (Epidemiology Department, Sanofi Pasteur MSD, Lyon, France) ;
Torcel-Pagnon, Laurence (Epidemiology Department, Sanofi Pasteur MSD, Lyon, France) ;
Cortés, Javier (Senior Consultant in Gynaecology Oncology, Spanish Society of Obstetrics and Gynaecology, Palma de Mallorca, Islas Baleares, Spain) ;
Castellsagué, Xavier (Institut Germans Trias i Pujol)
Human papillomavirus (HPV) is a sexually transmitted infection that may lead to development of precancerous and cancerous lesions of the cervix. The aim of the current study was to investigate socio-demographic, lifestyle, and medical factors for potential associations with cervical HPV infection in women undergoing cervical cancer screening in Spain. [...]
2012 - 10.1186/1471-2334-12-145
BMC Infectious diseases, Vol. 12 (june 2012) , p. 145
|
|
|
4.
|
|
12 p, 237.5 KB |
Human Papillomavirus (HPV) infection in pregnant women and mother-to-child transmission of genital HPV genotypes : a prospective study in Spain
/
Castellsagué, Xavier (Institut Català d'Oncologia) ;
Drudis, Teresa (European Institute of Oncology) ;
Cañadas Castillo, María de la Paz (General Lab (Barcelona, Catalunya)) ;
Goncé, Anna (Institut Clínic de Ginecologia, Obstetrícia i Neonatologia) ;
Ros, Ramón (Hospital de Sant Joan de Déu (Martorell, Catalunya)) ;
Pérez, José M. (Institut Clínic de Ginecologia, Obstetrícia i Neonatologia) ;
Quintana Ruiz, Maria Jesús (Institut d'Investigació Biomèdica Sant Pau) ;
Muñoz, Jesús (Institut Català d'Oncologia) ;
Albero Abril, Ginesa (Universitat Autònoma de Barcelona. Departament de Pediatria, d'Obstetrícia i Ginecologia i de Medicina Preventiva) ;
Sanjosé Llongueras, Silvia de (Institut Català d'Oncologia) ;
Bosch José, Francesc Xavier 1947- (Institut Català d'Oncologia) ;
Universitat Autònoma de Barcelona
Background: Studies on HPV infection in pregnant women and HPV transmission to the child have yielded inconsistent results. Methods: To estimate mother-to-child HPV transmission we carried out a prospective cohort study that included 66 HPV-positive and 77 HPV-negative pregnant women and their offspring attending a maternity hospital in Barcelona. [...]
2009 - 10.1186/1471-2334-9-74
BMC Infectious diseases, Vol. 9, N. 74 (May 2009) , p. 1-12
|
|
|
5.
|
|
10 p, 208.2 KB |
Male circumcision and prevalence of genital human papillomavirus infection in men : a multinational study
/
Albero Abril, Ginesa (Institut Català d'Oncologia) ;
Villa, Luisa L. (Ludwig Institute for Cancer Research (São Paulo, Brasil)) ;
Lazcano Ponce, Eduardo (Instituto Nacional de Salud Publica (Cuernavaca, Mèxic)) ;
Fulp, William (H. Lee Moffitt Cancer Center and Research Institute (Tampa, Estats Units d'Amèrica)) ;
Papenfuss, Mary R. (H. Lee Moffitt Cancer Center and Research Institute (Tampa, Estats Units d'Amèrica)) ;
Nyitray, Alan G. (H. Lee Moffitt Cancer Center and Research Institute (Tampa, Estats Units d'Amèrica)) ;
Lu, Beibei (H. Lee Moffitt Cancer Center and Research Institute (Tampa, Estats Units d'Amèrica)) ;
Castellsagué, Xavier (Institut Català d'Oncologia) ;
Abrahamsen, Martha (H. Lee Moffitt Cancer Center and Research Institute (Tampa, Estats Units d'Amèrica)) ;
Smith, Danélle (H. Lee Moffitt Cancer Center and Research Institute (Tampa, Estats Units d'Amèrica)) ;
Bosch José, Francesc Xavier 1947- (Institut Català d'Oncologia) ;
Salmerón, Jorge (Instituto Mexicano del Seguro Social) ;
Quiterio, Manuel (Instituto Nacional de Salud Publica (Cuernavaca, Mèxic)) ;
Giuliano, Anna R. (H. Lee Moffitt Cancer Center and Research Institute (Tampa, Estats Units d'Amèrica))
Background: Accumulated evidence from epidemiological studies and more recently from randomized controlled trials suggests that male circumcision (MC) may substantially protect against genital HPV infection in men. [...]
2013 - 10.1186/1471-2334-13-18
BMC Infectious diseases, Vol. 13, Núm. 18 (January 2013) , p. 1-10
|
|
|
6.
|
|
2 p, 158.3 KB |
La circumcisió masculina pot reduir el risc de contraure algunes malalties de transmissió sexual
/
Castellsagué, Xavier (Universitat Autònoma de Barcelona. Departament de Pediatria, d'Obstetrícia i Ginecologia i de Medicina Preventiva) ;
Albero Abril, Ginesa (Universitat Autònoma de Barcelona. Departament de Pediatria, d'Obstetrícia i Ginecologia i de Medicina Preventiva) ;
Bosch José, Francesc Xavier 1947- (Universitat Autònoma de Barcelona. Departament de Pediatria, d'Obstetrícia i Ginecologia i de Medicina Preventiva)
Uns resultats sorprenents que ara ja gaudeixen d'evidència científica. Mitjançant un estudi multicèntric de més de 1000 dones amb les seves respectives parelles, es va aconseguir quantificar per primer cop la sospita que existia entre la comunitat científica: que la circumcisió masculina s'associa a un menor risc de virus del papiloma humà (VPH) al penis, i un risc menor de càncer de coll d'úter en la seva parella. [...]
Unos resultados sorprendentes que ahora ya gozan de evidencia científica. Mediante un estudio multicéntrico de más de 1000 mujeres con sus respectivas parejas, se logró cuantificar por primera vez la sospecha que existía entre la comunidad científica: que la circuncisión masculina se asocia a un menor riesgo de Virus del Papiloma Humano (VPH) en el pene, y un menor riesgo de cáncer de cuello de útero en su pareja. [...]
2009
UAB divulga, Abril 2009, p. 1-2
2 documents
|
|
visitant ::
identificació
alerta personal via correu electrònic o subscribiu-vos al 
canal RSS.
